[HTML][HTML] Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
Background Merkel cell carcinoma (MCC) is a rare, aggressive, cutaneous neuroendocrine
neoplasm with annual incidence rates of 0.13–1.6 cases/100,000/year worldwide as of …
neoplasm with annual incidence rates of 0.13–1.6 cases/100,000/year worldwide as of …
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ
MS Trivedi, AM Coe, A Vanegas, R Kukafka… - Cancer Prevention …, 2017 - AACR
Women with atypical hyperplasia and lobular or ductal carcinoma in situ (LCIS/DCIS) are at
increased risk of developing invasive breast cancer. Chemoprevention with selective …
increased risk of developing invasive breast cancer. Chemoprevention with selective …
[HTML][HTML] Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting
Background Breast cancer chemoprevention can reduce breast cancer incidence in high-
risk women; however, chemoprevention is underutilized in the primary care setting. We …
risk women; however, chemoprevention is underutilized in the primary care setting. We …
The effect of coping strategies on the risk for suicidal ideation and behavior in adolescents
AS Gómez-Tabares, JPC Marín, AM Vanegas… - … Journal of Clinical …, 2022 - cab.unime.it
The aim of this paper was to analyze the predictive effect of coping strategies on the risk for
suicidal ideation and behavior in 309 adolescents between 11 and 18 years of age (M …
suicidal ideation and behavior in 309 adolescents between 11 and 18 years of age (M …
[HTML][HTML] Usability testing of a web-based decision aid for breast cancer risk assessment among multi-ethnic women
AM Coe, W Ueng, JM Vargas, R David… - AMIA Annual …, 2016 - ncbi.nlm.nih.gov
Chemoprevention with antiestrogens could decrease the incidence of invasive breast
cancer but uptake has been low among high-risk women in the United States. We have …
cancer but uptake has been low among high-risk women in the United States. We have …
Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women
JE McGuinness, W Ueng, MS Trivedi, HS Yi… - … Biomarkers & Prevention, 2018 - AACR
Background: Potential harms of screening mammography include false positive results, such
as recall breast imaging or biopsies. Methods: We recruited women undergoing screening …
as recall breast imaging or biopsies. Methods: We recruited women undergoing screening …
[HTML][HTML] Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care
TB Silverman, A Vanegas, A Marte, J Mata… - BMC health services …, 2018 - Springer
Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing
breast cancer to those who carry them. For this reason, the United States Preventative …
breast cancer to those who carry them. For this reason, the United States Preventative …
[HTML][HTML] Automatic genetic risk assessment calculation using breast cancer family history data from the EHR compared to self-report
M Sin, JE McGuinness, MS Trivedi… - AMIA Annual …, 2018 - ncbi.nlm.nih.gov
Genetic testing is a method to assess hereditary cancer risk. However, it is under-utilized
and various methods of family history intake have been evaluated in previous studies. The …
and various methods of family history intake have been evaluated in previous studies. The …
[HTML][HTML] Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer …
KD Crew, TB Silverman, A Vanegas, MS Trivedi… - Contemporary Clinical …, 2019 - Elsevier
Background Chemoprevention using selective estrogen receptor modulators and aromatase
inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women …
inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women …
[HTML][HTML] An applied framework in support of shared decision making about BRCA genetic testing
TB Silverman, GJ Kuperman, A Vanegas… - AMIA Annual …, 2018 - ncbi.nlm.nih.gov
Abstract The United States Preventive Services Taskforce recommends that primary care
providers screen patients for an increased risk of carrying a BRCA1 or BRCA2 mutation and …
providers screen patients for an increased risk of carrying a BRCA1 or BRCA2 mutation and …